Amarin reported $225.77M in Stock for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amarin AMRN:US $ 225.77M 42.05M
Biocryst Pharmaceuticals BCRX:US $ 23.38M 7.23M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
GlaxoSmithKline GSK:LN 4664M 1339M
Halozyme Therapeutics HALO:US $ 97.62M 49.85M
Heron Therapeutics HRTX:US $ 61.32M 4.85M
IONIS PHARMACEUT IONS:US $ 19.81M 4.22M
JAZZ PHA JAZZ:US $ 861.7M 123.75M
Nektar Therapeutics NKTR:US $ 16.97M 1.59M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Novartis NOVN:VX SF 6880M 117M